Amgen Inc. (AMGN) Shareholders & Insider Trades

Executive TeamFinancialsSegmentsShareholders

Amgen shareholders at a glance

The largest holder of Amgen stock is BlackRock Advisors LLC, with 36.7 million shares (6.79% of the company), worth about $15.77 billion as of September 25, 2026. The 10 largest holders together own 40.4%.

In Q2 2026, 3,277 institutional holdings reports listed shares worth $163.00 billion.

Insiders reported 108 transactions in the last two years: 17 sales worth $53.73 million and no purchases. The newest one on file is from August 13, 2026 (Khosla Rachna, Officer).

Major holders as of September 25, 2026; quarterly totals from institutional holdings reports (latest Q2 2026); insider transactions on file through August 13, 2026.

AMGN logo

Amgen Inc.

AMGNUnited States
Healthcare

Shareholders Summary

2026Q2

Filings
3277
Options Value
$3.76B
Value (excl. Options)
$163.00B
Shares (excl. Options)
-

Ownership by Type

Geographic Distribution

Largest Amgen shareholders

HolderShares% of companyValue
BlackRock Advisors LLC36.7 million6.79%$15.8B
Vanguard Capital Management LLC35.3 million6.52%$15.2B
State Street Corporation30.6 million5.65%$13.1B
Capital Research & Management Co. (World Investors)29.1 million5.38%$12.5B
Invesco Advisers, Inc.16.3 million3.02%$7.0B
Geode Capital Management LLC15.7 million2.90%$6.7B
Charles Schwab Investment Management, Inc.15.0 million2.78%$6.5B
Vanguard Portfolio Management LLC14.9 million2.75%$6.4B
Eaton Vance Management13.7 million2.53%$5.9B
Ishares (DE) InvAG mit Teilgesellschaftsvermogen11.5 million2.12%$4.9B

As of September 25, 2026.

Amgen institutional holdings by quarter

QuarterReportsSharesValue
Q2 20263,277–$163.0B
Q1 20263,265440.0 million$154.0B
Q4 20253,223451.0 million$147.0B
Q3 20252,966427.0 million$121.0B
Q2 20252,996438.0 million$122.0B
Q1 20253,073429.0 million$134.0B
Q4 20243,006419.0 million$109.0B
Q3 20242,965419.0 million$135.0B

Shares and value held by institutions that file quarterly holdings reports (options not included).

Amgen insider trades

InsiderDateTitleTransactionValue
Khosla RachnaAug 13, 2026OfficerSale at price 412.57 - 416.43 per share.$1.3M
Khosla RachnaAug 13, 2026OfficerConversion of Exercise of derivative security at price 162.60 per share.$203,575
Busch Matthew C.Aug 7, 2026OfficerStock Award(Grant) at price 0.00 per share.–
Drake Michael VAug 7, 2026DirectorStock Award(Grant) at price 0.00 per share.–
Ishrak Omar SyedAug 7, 2026DirectorStock Award(Grant) at price 0.00 per share.–
Holley Charles M JrAug 7, 2026DirectorStock Award(Grant) at price 0.00 per share.–
Grygiel Nancy AAug 6, 2026OfficerSale at price 402.16 per share.$1.2M
Miller DerekAug 6, 2026OfficerSale at price 402.54 per share.$1.6M
Grygiel Nancy AAug 6, 2026OfficerConversion of Exercise of derivative security at price 177.31 - 177.46 per share.$526,906
Miller DerekAug 6, 2026OfficerConversion of Exercise of derivative security at price 162.60 - 177.46 per share.$659,574
Klotman Mary EMay 19, 2026DirectorStock Award(Grant) at price 0.00 per share.–
Drake Michael VMay 19, 2026DirectorStock Award(Grant) at price 0.00 per share.–

Newest 12 of 108 insider transactions in the last two years.

Questions and answers

Who owns the most Amgen stock?

BlackRock Advisors LLC, with 6.79% of the company (as of September 25, 2026). Next: Vanguard Capital Management LLC (6.52%) and State Street Corporation (5.65%).

How many institutions own Amgen stock?

3,277 institutional holdings reports listed Amgen shares in Q2 2026 worth $163.00 billion.

Are Amgen insiders buying or selling the stock?

In the last two years insiders reported 17 sales and no purchases (108 transactions in all); the newest on file is from August 13, 2026.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.
LinkedInLinkedInXXYouTubeYouTube